Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

112 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cryoablation of small renal masses in patients with solitary kidneys: worth crossing the road for?
Bertolo R, Amparore D, Diana P, Erdem S, Marandino L, Carbonara U, Borregales LD, Muselaers S, Pavan N, Pecoraro A, Roussel E, Pecoraro A, Marchioni M, Campi R; EAU Young Academic Urologists (YAU) Renal Cancer working group. Bertolo R, et al. Among authors: marandino l. Minerva Urol Nephrol. 2022 Dec;74(6):794-798. doi: 10.23736/S2724-6051.22.05184-9. Minerva Urol Nephrol. 2022. PMID: 36629808 Free article. No abstract available.
Is Adjuvant Immunotherapy Worth for All Patients with Clear-cell Renal Cell Carcinoma at High Risk of Recurrence?
Marchioni M, Amparore D, Marandino L, Bertolo R, Erdem S, Ingels A, Muselaers S, Kara O, Pavan N, Roussel E, Carbonara U, Pecoraro A, Diana P, Pecoraro A, Campi R; European Association of Urology Young Academic Urologists Renal Cancer Working Group. Marchioni M, et al. Among authors: marandino l. Eur Urol Open Sci. 2022 Oct 25;46:39-42. doi: 10.1016/j.euros.2022.10.002. eCollection 2022 Dec. Eur Urol Open Sci. 2022. PMID: 36325369 Free PMC article. No abstract available.
Deficiencies in health-related quality-of-life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016.
Marandino L, La Salvia A, Sonetto C, De Luca E, Pignataro D, Zichi C, Di Stefano RF, Ghisoni E, Lombardi P, Mariniello A, Reale ML, Trevisi E, Leone G, Muratori L, Marcato M, Bironzo P, Novello S, Aglietta M, Scagliotti GV, Perrone F, Di Maio M. Marandino L, et al. Ann Oncol. 2018 Dec 1;29(12):2288-2295. doi: 10.1093/annonc/mdy449. Ann Oncol. 2018. PMID: 30304498 Free article.
Quality-of-Life Assessment and Reporting in Prostate Cancer: Systematic Review of Phase 3 Trials Testing Anticancer Drugs Published Between 2012 and 2018.
Marandino L, De Luca E, Zichi C, Lombardi P, Reale ML, Pignataro D, Di Stefano RF, Ghisoni E, Mariniello A, Trevisi E, Leone G, Muratori L, La Salvia A, Sonetto C, Buttigliero C, Tucci M, Aglietta M, Novello S, Scagliotti GV, Perrone F, Di Maio M. Marandino L, et al. Clin Genitourin Cancer. 2019 Oct;17(5):332-347.e2. doi: 10.1016/j.clgc.2019.07.007. Epub 2019 Jul 20. Clin Genitourin Cancer. 2019. PMID: 31416754
Quality of life analysis in lung cancer: A systematic review of phase III trials published between 2012 and 2018.
Reale ML, De Luca E, Lombardi P, Marandino L, Zichi C, Pignataro D, Ghisoni E, Di Stefano RF, Mariniello A, Trevisi E, Leone G, Muratori L, La Salvia A, Sonetto C, Bironzo P, Aglietta M, Novello S, Scagliotti GV, Perrone F, Di Maio M. Reale ML, et al. Among authors: marandino l. Lung Cancer. 2020 Jan;139:47-54. doi: 10.1016/j.lungcan.2019.10.022. Epub 2019 Oct 31. Lung Cancer. 2020. PMID: 31734586
Quality of life assessment and reporting in colorectal cancer: A systematic review of phase III trials published between 2012 and 2018.
Lombardi P, Marandino L, De Luca E, Zichi C, Reale ML, Pignataro D, Di Stefano RF, Ghisoni E, Mariniello A, Trevisi E, Leone G, Muratori L, La Salvia A, Sonetto C, Leone F, Aglietta M, Novello S, Scagliotti GV, Perrone F, Di Maio M. Lombardi P, et al. Among authors: marandino l. Crit Rev Oncol Hematol. 2020 Feb;146:102877. doi: 10.1016/j.critrevonc.2020.102877. Epub 2020 Jan 18. Crit Rev Oncol Hematol. 2020. PMID: 31981880 Free article.
Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy.
Ghisoni E, Wicky A, Bouchaab H, Imbimbo M, Delyon J, Gautron Moura B, Gérard CL, Latifyan S, Özdemir BC, Caikovski M, Pradervand S, Tavazzi E, Gatta R, Marandino L, Valabrega G, Aglietta M, Obeid M, Homicsko K, Mederos Alfonso NN, Zimmermann S, Coukos G, Peters S, Cuendet MA, Di Maio M, Michielin O. Ghisoni E, et al. Among authors: marandino l. Eur J Cancer. 2021 May;149:153-164. doi: 10.1016/j.ejca.2021.03.010. Epub 2021 Apr 14. Eur J Cancer. 2021. PMID: 33865201 Free article.
112 results